Digitorenocerebral syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1674
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Digitorenocerebral syndrome, also known as Eronen syndrome, is an extremely rare autosomal recessive condition characterized by a combination of digital (finger and toe), renal (kidney), and cerebral (brain) anomalies. The syndrome was first described in a small number of affected individuals and is notable for its multisystem involvement presenting at birth or early infancy. Key clinical features include digital anomalies such as hypoplastic (underdeveloped) or absent thumbs and other finger malformations, severe renal abnormalities including renal agenesis or dysplasia, and central nervous system malformations such as Dandy-Walker malformation, cerebellar hypoplasia, and other structural brain defects. Additional features may include growth retardation, craniofacial dysmorphism, and ocular abnormalities. The combination of these malformations can lead to significant morbidity, and the prognosis is often poor, particularly when severe renal and brain anomalies are present. There is currently no specific or curative treatment for digitorenocerebral syndrome. Management is supportive and symptomatic, focusing on addressing individual organ system involvement. This may include nephrology care for renal complications, neurodevelopmental support, and surgical interventions for digital or other structural anomalies when feasible. Genetic counseling is recommended for affected families.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Nov 2024Surveillance of AMR in DRC

University of Oxford

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Digitorenocerebral syndrome.

View clinical trials →

No actively recruiting trials found for Digitorenocerebral syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Digitorenocerebral syndrome community →

No specialists are currently listed for Digitorenocerebral syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Digitorenocerebral syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Digitorenocerebral syndromeForum →

No community posts yet. Be the first to share your experience with Digitorenocerebral syndrome.

Start the conversation →

Latest news about Digitorenocerebral syndrome

Disease timeline:

New recruiting trial: Surveillance of AMR in DRC

A new clinical trial is recruiting patients for Digitorenocerebral syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Digitorenocerebral syndrome

What is Digitorenocerebral syndrome?

Digitorenocerebral syndrome, also known as Eronen syndrome, is an extremely rare autosomal recessive condition characterized by a combination of digital (finger and toe), renal (kidney), and cerebral (brain) anomalies. The syndrome was first described in a small number of affected individuals and is notable for its multisystem involvement presenting at birth or early infancy. Key clinical features include digital anomalies such as hypoplastic (underdeveloped) or absent thumbs and other finger malformations, severe renal abnormalities including renal agenesis or dysplasia, and central nervous

How is Digitorenocerebral syndrome inherited?

Digitorenocerebral syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Digitorenocerebral syndrome typically begin?

Typical onset of Digitorenocerebral syndrome is neonatal. Age of onset can vary across affected individuals.